Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nasheed M, Hossain"'
Autor:
Mazyar Shadman, Kwang W. Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M. Hossain, Peter Riedell, Ajay K. Gopal, Natalie Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid Merryman, Aleksandr Lazaryan, Ron Ram, Mark Hertzberg, Bipin Savani, Farrukh Awan, Farhad Khimani, Sairah Ahmed, Vaishalee P. Kenkre, Matthew Ulrickson, Nirav Shah, Mohamed A. Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We compared the efficacy
Externí odkaz:
https://doaj.org/article/e8520ed8a9ea4ad4a6eebc0252da84a4
Autor:
Farinoosh Dadrass, Fatema Esmail, Aayushma Regmi, Kumaran Mudaliar, Kamran M. Mirza, Ameet R. Kini, Wendy Kim, Patrick Hagen, Nasheed M. Hossain
Publikováno v:
Clinical Case Reports, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract Acute myeloid leukemia (AML) arises from clonal expansion of malignant hematopoietic precursor cells in the bone marrow. In rare instances, AML can recur with prominent extramedullary manifestations (i.e., leukemia cutis or myeloid sarcoma),
Externí odkaz:
https://doaj.org/article/3fcdc061c12f4cf0b84b8f40a5e5c485
Autor:
Suzanne Quinn, Natasha Lenart, Victoria Dronzek, Gina M. Scurti, Nasheed M. Hossain, Michael I. Nishimura
Publikováno v:
Vaccines, Vol 10, Iss 3, p 457 (2022)
Immunotherapy is a beneficial treatment approach for multiple cancers, however, current therapies are effective only in a small subset of patients. Adoptive cell transfer (ACT) is a facet of immunotherapy where T cells targeting the tumor cells are t
Externí odkaz:
https://doaj.org/article/a143d7add8e7460fbf251ae60183ed45
Autor:
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D'Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Publikováno v:
Blood Advances, Vol 2, Iss 8, Pp 933-940 (2018)
Abstract: The application of allogeneic hematopoietic cell transplantation (allo-HCT) in non-Hodgkin lymphoma (NHL) patients ≥65 years in the United States is limited by lack of Medicare coverage for this indication. Using the Center for Internatio
Externí odkaz:
https://doaj.org/article/e1f7f92829604e7783e85b8341e07274
Autor:
Estefania Gauto-Mariotti, Amanda J. Nguyen, Chloe Waters, Gina M. Scurti, Sandra Haddad, Milind M. Velankar, Annika V. Dalheim, Victoria Dronzek, Rhett P. Ketterling, Michael I. Nishimura, Joanna C. Dalland, Nasheed M. Hossain
Publikováno v:
Journal of Hematopathology. 15:229-237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1767ee53e821871154f3811f6635f645
https://doi.org/10.1007/s12308-022-00519-2
https://doi.org/10.1007/s12308-022-00519-2
Autor:
Erin A. Dean, Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed M. Hossain, Michael D. Jain, Saurabh Dahiya, David B Miklos, Philipp M Altrock, Frederick L. Locke
Publikováno v:
Blood Advances.
We examined the meaning of metabolically active lesions on 1 month restaging nuclear imaging of patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) receiving axicabtagene ciloleucel (axi-cel) by assessing the relationship between tot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bea1b6362c3ec99bd2c303a4cd44fe6
https://doi.org/10.1182/bloodadvances.2022009426
https://doi.org/10.1182/bloodadvances.2022009426
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Sherif M. Badawy, Amer Beitinjaneh, Chris Bredeson, Jean-Yves Cahn, Jan Cerny, Miguel Angel Diaz Perez, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Usama Gergis, Gerhard C. Hildebrandt, Michael R. Grunwald, Shahrukh Hashmi, Nasheed M. Hossain, Matt Kalaycio, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Betty Ky Hamilton, Hillard M. Lazarus, Jane Liesveld, Mark Litzow, David I. Marks, Hemant S. Murthy, Sunita Nathan, Aziz Nazha, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Bipin Savani, Sachiko Seo, Melhem Solh, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, Ravi Vij, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber
Publikováno v:
JAMA Oncology, 8(3), 404-411. American Medical Association
JAMA Oncol
JAMA Oncol
Importance Matched sibling donors (MSDs) are preferred for allogeneic hematopoietic cell transplantation (allo-HCT) in myelodysplastic syndrome even if they are older. However, whether older MSDs or younger human leukocyte antigen-matched unrelated d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639bda17f43fbaee45fe98e0c1f19058
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
Autor:
Catherine J. Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R. Spellman, Carrie Kitko, Margaret L. MacMillan, Joseph A. Pidala, Jeffery J. Auletta, Sherif M. Badawy, Neel Bhatt, Vijaya R. Bhatt, Jean-Yves Cahn, Zachariah DeFilipp, Miguel A. Diaz, Nosha Farhadfar, Shahinaz Gadalla, Robert P. Gale, Hasan Hashem, Shahrukh Hashmi, Peiman Hematti, Sanghee Hong, Nasheed M. Hossain, Yoshihiro Inamoto, Lazaros J. Lekakis, Dipenkumar Modi, Sager Patel, Akshay Sharma, Scott Solomon, Daniel R. Couriel
Publikováno v:
Transplantation and cellular therapy. 28(10)
Chronic graft-versus-host disease (cGVHD) occurs in up to 25% of children following allogeneic hematopoietic cell transplantation (HCT) and continues to be a major cause of late morbidity and poor quality of life among long-term survivors of pediatri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a3d09f0403b75cd5cff907ea33f639
https://pubmed.ncbi.nlm.nih.gov/35863740
https://pubmed.ncbi.nlm.nih.gov/35863740
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24492 (2011)
Eukaryotic initiation factor 2A is a single polypeptide that acts to negatively regulate IRES-mediated translation during normal cellular conditions. We have found that eIF2A (encoded by YGR054w) abundance is reduced at both the mRNA and protein leve
Externí odkaz:
https://doaj.org/article/f01c23b9c5c0480faccfdcae290a4f83
Autor:
Narendranath, Epperla, Kami J, Maddocks, Mohammed, Salhab, Julio C, Chavez, Nishitha, Reddy, Reem, Karmali, Elvira, Umyarova, Veronika, Bachanova, Cristiana, Costa, Martha, Glenn, Oscar, Calzada, Ana C, Xavier, Zheng, Zhou, Nasheed M, Hossain, Francisco J, Hernandez-Ilizaliturri, Zeina, Al-Mansour, Stefan K, Barta, Saurabh, Chhabra, Frederick, Lansigan, Amitkumar, Mehta, Michael V, Jaglal, Andrew M, Evens, Christopher R, Flowers, Jonathon B, Cohen, Timothy S, Fenske, Mehdi, Hamadani, Luciano J, Costa
Publikováno v:
Cancer. 123(22)
The impact of MYC proto-oncogene, basic helix-loop-helix (MYC) translocations (with or without additional rearrangements involving the B-cell lymphoma 2 [BCL2] or BCL6 genes) on the response to salvage therapy and survival in patients with diffuse la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8bba69819e486a2bb5ad6b93a4e59fc
https://pubmed.ncbi.nlm.nih.gov/29406586
https://pubmed.ncbi.nlm.nih.gov/29406586